- Home
- FRES vs PSTV Comparison
FRES vs PSTV Comparison
Compare FRES & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRES
- PSTV
- Stock Information
- Founded
- FRES 2010
- PSTV 1996
- Country
- FRES United States
- PSTV United States
- Employees
- FRES N/A
- PSTV N/A
- Industry
- FRES Medical Specialities
- PSTV Medical/Dental Instruments
- Sector
- FRES Health Care
- PSTV Health Care
- Exchange
- FRES Nasdaq
- PSTV Nasdaq
- Market Cap
- FRES N/A
- PSTV 9.4M
- IPO Year
- FRES 2020
- PSTV N/A
- Fundamental
- Price
- FRES $1.66
- PSTV $1.40
- Analyst Decision
- FRES
- PSTV Strong Buy
- Analyst Count
- FRES 0
- PSTV 2
- Target Price
- FRES N/A
- PSTV $14.00
- AVG Volume (30 Days)
- FRES 32.8K
- PSTV 86.1K
- Earning Date
- FRES 10-29-2024
- PSTV 10-29-2024
- Dividend Yield
- FRES N/A
- PSTV N/A
- EPS Growth
- FRES N/A
- PSTV N/A
- EPS
- FRES N/A
- PSTV N/A
- Revenue
- FRES $2,341,326.00
- PSTV $5,509,000.00
- Revenue This Year
- FRES N/A
- PSTV $11.13
- Revenue Next Year
- FRES N/A
- PSTV N/A
- P/E Ratio
- FRES N/A
- PSTV N/A
- Revenue Growth
- FRES 94.50
- PSTV 113.20
- 52 Week Low
- FRES $1.11
- PSTV $0.97
- 52 Week High
- FRES $18.00
- PSTV $2.78
- Technical
- Relative Strength Index (RSI)
- FRES 51.75
- PSTV 48.32
- Support Level
- FRES $1.51
- PSTV $1.20
- Resistance Level
- FRES $2.36
- PSTV $1.45
- Average True Range (ATR)
- FRES 0.19
- PSTV 0.11
- MACD
- FRES 0.06
- PSTV 0.01
- Stochastic Oscillator
- FRES 38.60
- PSTV 66.67
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).